William A. Frazier
GET FULL PROFILE 
Real-Time AI Research
FlashIntel GPT
Tell me more about William A. Frazier?
FlashIntel GPTWilliam A. Frazier is a Ph.D. co-founder of Arch Oncology, a research-focused company based in the United States. He has extensive experience in the field, having founded the company from his laboratory and from the National Institutes of Health. Dr. Frazier is known for his expertise in CD47-mediated signaling pathways and has contributed to over 140 publications. He is also a professor of Biochemistry, Molecular Biophysics, and Cell Biology at Washington University School of Medicine.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
William Frazier, Ph.D. co-founded the Company based on research from his laboratory and from the National Institutes of Health. He discovered that CD47 is a receptor for thrombospondin-1 and has been a leader in the field of CD47-mediated signaling pathways, contributing to over 140 publications. Dr. Frazier is a professor of Biochemistry, Molecular Biophysics, and Cell Biology at Washington University School of Medicine.
Work Experience
Co-Founder
Biotechnology Research
William A. Frazier's Professional Milestones
- Co-Founder: Building a successful startup from the ground up, launching a unique product and setting life for the company.
Certification
Colleagues
David Boisvert
Vice President | Process Development | Manufacturing | Supply Chain
Ronald Krasnow
Chief Operating Officer
Dan Zavodnick
Vice President Legal
Jeff Petty
Senior Director Regulatory Affairs
Dan Pereira
Chief Scientific Officer
Other Named William A. Frazier
Frequently asked questions
We found 1 William A. Frazier's email addresses
We found 1 William A. Frazier's phone numbers
William A. Frazier works for Arch Oncology
William A. Frazier's role in Arch Oncology is Co-Founder
William A. Frazier works in the industry of Biotechnology Research
William A. Frazier's colleagues are David Boisvert,Ronald Krasnow,Dan Zavodnick
William A. Frazier's latest job experience is Co-Founder at Arch Oncology
